The N-terminal half of EBNA2, except for seven prolines, is not essential for primary B-lymphocyte growth transformation

Journal of Virology

Volumn 70, Issue 4, 1996, Pages 2468-2473

  Yalamanchili, Ramana ^a   Harada, Shizuko ^a   Kieff, Elliott ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA BINDING PROTEIN; NUCLEAR PROTEIN; PROLINE; VIRUS PROTEIN;

AMINO TERMINAL SEQUENCE; ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; EPSTEIN BARR VIRUS; GENE DELETION; LYMPHOBLASTOID CELL LINE; LYMPHOCYTE TRANSFORMATION; MUTATION; PRIORITY JOURNAL; PROMOTER REGION; TRANSACTIVATION; VIRUS TRANSFORMATION;

EID: 0029963888     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.70.4.2468-2473.1996     Document Type: Article

References (27)

1. Alfieri, C., M. Birkenbach, and E. Kieff, 1991. Early events in Epstein-Barr virus infection of human B lymphocytes. Virology 181:595-608
2. Chen, H., and M. Sudol. 1995. The WW domain of Yes-associated protein binds a proline-rich ligand that differs from the concensus established for Src homology 3-binding modules. Proc. Natl. Acad Sci. USA 92:7814-7823.
3. Cohen, J. I., F. Wang, and E. Kieff. 1991. Epstein-Barr virus nuclear protein 2 mutations define essential domains for transformation and transactivation. J. Virol. 65:2545-2554.
4. Cohen, J. I., F. Wang, J. Mannick, and E. Kieff. 1989. Epstein-Barr virus nuclear protein 2 is a key determinant of lymphocyte transformation Proc. Natl. Acad. Sci. USA 86:9558-9562.
5. Cordier, M., A. Calendar, M. Billaud, U. Zimber, G. Rousselet, O. Pavlish, J. Banchereau, T. Tursz, G. Bornkamm, and G. M. Lenoir. 1990 Stable transfection of Epstein-Barr virus (EBV) nuclear antigen 2 in lymphoma cells containing the EBV P3HR1 genome induces expression of B-cell activation molecules CD21 and CD23. J. Virol. 64:1002-1013.
6. Dambaugh, T., K. Hennessy, L. Chamnankit, and E. Kieff. 1984 U2 region of Epstein-Barr virus DNA may encode Epstein-Barr nuclear antigen 2. Proc Natl Acad. Sci. USA 81:7632-7636.
7. Dillner, J., and B. Kallin. 1988. The Epstein-Barr virus proteins Adv. Cancer Res 50:95-158.
8. Grossman, S. R., E. Johannsen, X. Tong, R. Yalamanchili, and E. Kieff. 1994. The Epstein-Barr virus nuclear antigen 2 transactivator is directed to response elements by the J kappa recombination signal binding protein Proc. Natl. Acad. Sci. USA 91:7568-7572.
9. Hammerschmidt, W., and B. Sugden. 1989. Genetic analysis of immortalizing functions of Epstein-Barr virus in human B lymphocytes. Nature (London) 340:393-397
10. Henkel, T., P. D. Ling, S. D. Hayward, and M. G. Peterson. 1994 Mediation of Epstein-Barr virus EBNA2 transactivation by recombination signal-binding protein Jk. Science 265:92-95.
11. Higuchi, R. 1990. Recombinant PCR, p. 177-183. In M. A. Innis (ed.), PCR protocols: a guide to methods and applications Academic Press, San Diego, Calif.
12. Johannsen, E., E. Koh, G. Mosialos, X. Tong, E. Kieff, and S. Grossman. 1995 Epstein-Barr virus nuclear protein 2 transactivation of the latent membrane protein 1 promoter is mediated by JK and PU.1. J. Virol 69:253-262
13. Ling, P. D., J. J. Ryon, and S. D. Hayward. 1993. EBNA-2 of herpesvirus papio diverges significantly from the type A and type B EBNA-2 proteins of Epstein-Barr virus but retains an efficient transactivation domain with a conserved hydrophobic motif. J. Virol. 67:2990-3003.
14. Menezes, J., W. Leiboled, G. Klein, and G. Clements. 1975 Establishment and characterization of an Epstein-Barr virus (EBV)-negative lymphoblastoid B cell line (BJA-B) from an exceptional, EBV- genome-negative African Burkitt's lymphoma. Biomedicine 22:276-284.
15. Miller, G., J. Robinson, L. Heston, and M. Lipman. 1974. Differences between laboratory strains of Epstein-Barr virus based on immortalization, abortive infection, and interference. Proc. Natl. Acad. Sci. USA 71:4006-4010.
16. Reth, M. 1989. Antigen receptor tail cue. Nature (London) 338:383-384.
17. Rooney, C., G. Howe, S. H. Speck, and G. Miller. 1989 Influences of Burkitt's lymphoma and primary B cells on latent gene expression by the non-immortalizing P3J-HR-1 strain of Epstein-Barr virus. J. Virol. 63:1531-1539.
18. Tong, X., R. Drapkin, D. Reinberg, and E. Kieff. 1995. The 62- and 80-kDa subunits of transcription factor IIH mediate the interaction with Epstein Barr virus nuclear protein 2. Proc. Natl. Acad. Sci. USA 92:3259-3263.
19. Tong, X., R. Drapkin, R. Yalamanchili, G. Mosialos, and E. Kieff. 1995. The Epstein-Barr virus nuclear protein 2 acidic domain forms a complex with a novel cellular coactivator that can interact with TFIIE. Mol. Cell. Biol. 15:4735-4744.
20. Tong, X., F. Wang, C. J. Thut, and E. Kieff. 1995. The Epstein-Barr virus nuclear protein 2 acidic domain can interact with TFIIB, TAF40, and RPA70 but not with TATA-binding protein. J. Virol. 69:585-588.
21. Tong, X., R. Yalamanchili, S. Harada, and E. Kieff. 1994 The EBNA-2 arginine-glycine domain is critical but not essential for B-lymphocyte growth transformation; the rest of region 3 lacks essential interactive domains. J. Virol. 68:6188-6197.
22. Tsang, S. F., F. Wang, K. M. Izumi, and E. Kieff. 1991. Delineation of the cis-acting element mediating EBNA-2 transactivation of latent infection membrane protein expression. J. Virol. 65:6765-6771.
23. Wang, F., C. D. Gregory, M. Rowe, A. B. Rickinson, D. Wang, M. Birkenbach, H. Kikutani, T. Kishimoto, and E. Kieff. 1987. Epstein Barr virus nuclear antigen 2 specifically induces expression of the B-cell activation antigen CD23. Proc. Natl. Acad. Sci. USA 84:3452-3456.
24. Yalamanchili, R., X. Tong, S. Grossman, E. Johannsen, G. Mosialos, and E. Kieff. 1994. Genetic and biochemical evidence that EBNA2 interaction with a 63-kDa cellular GTG-binding protein is essential for B lymphocyte growth transformation by EBV Virology 204:634-641.
25. Yu, H., J. K. Chen, S. Feng, D. C. Dalgarno, A. W. Brauer, and S. L. Shreiber. 1994. Structural basis for the binding of proline-rich peptides to SH3 domains. Cell 76:933-945.
26. 25a.Zheng, C., and E. Kieff. Unpublished observation.
27. Zimber-Strobl, U., E. Kremmer, F. Grasser, G. Marschall, G. Laux, and G. Bornkamm. 1993. The Epstein-Barr virus nuclear antigen 2 interacts with an EBNA2 responsive cis-element of the terminal protein 1 gene promoter. EMBO J. 12:167-175